Search Results - "Chung, Yoo-Ri"

Idiopathic Photoreceptoritis: An Unusual Variant of Outer Retinopathy.

Authors: Chung, Yoo-Ri Toutée, Adélaïde Titah, Chérif et al.

Source: Ocular Immunology & Inflammation. Jul2025, Vol. 33 Issue 5, p875-878. 4p.

Atypical Mid-Late Phase ICGA Hyperfluorescence in a Secondary MEWDS Case: A Distinct Disease or a Shift in Our Understanding of MEWDS?

Authors: Touhami, Sara Chung, Yoo-Ri March, Francesc et al.

Source: Ocular Immunology & Inflammation. Sep2025, Vol. 33 Issue 7, p1468-1471. 4p.

Efficacy of Tumor Necrosis Factor-α Inhibitor Adalimumab in Chronic Recurrent Vogt–Koyanagi–Harada Disease.

Authors: Lee, Junghoo Chung, Yoo-Ri Kim, Hae Rang et al.

Source: Pharmaceuticals (14248247). Dec2025, Vol. 18 Issue 12, p1848. 15p.

Diagnostic Performance of Universal Transport Medium for Viral Polymerase Chain Reaction in Aqueous Humor Samples of Suspected Viral Uveitis: A Pilot Methods Study.

Authors: Kim, Chungwoon Chung, Yoo-Ri Song, Ji Hun et al.

Source: International Journal of Molecular Sciences. Oct2025, Vol. 26 Issue 20, p10091. 13p.

Efficacy of Internal Limiting Membrane Peeling in Eyes with Proliferative Diabetic Retinopathy: A Meta-Analysis.

Authors: Chung, Yoo-Ri Lee, Eunzee Kim, Hanju et al.

Source: Ophthalmologica. 2025, Vol. 248 Issue 5/6, p386-400. 15p.

Anatomical, Functional, and Prognostic Results of Vitrectomy in Epiretinal Membranes Secondary to Retinal Vein Occlusions.

Authors: Chung, Yoo-Ri Mainguy, Adam Chatziralli, Irini et al.

Source: Ophthalmologica. 2025, Vol. 248 Issue 1, p29-39. 11p.

Efficacy and Safety of Switching from Adalimumab Originator to SB5 Biosimilar in Noninfectious Uveitis: Early Clinical Outcomes.

Authors: Song, Ji Hun Kim, Chungwoon Chung, Yoo-Ri et al.

Source: Journal of Clinical Medicine. Nov2025, Vol. 14 Issue 22, p8179. 12p.

Corrigendum to "Ursodeoxycholic Acid Attenuates Endoplasmic Reticulum Stress‐Related Retinal Pericyte Loss in Streptozotocin‐Induced Diabetic Mice".

Authors: Chung, Yoo-Ri Choi, Jeong A. Koh, Jae-Young et al.

Source: Journal of Diabetes Research. 7/17/2024, Vol. 2024, p1-2. 2p.

Demographic and Multimodal Imaging Features of Macular Telangiectasia Type 2: Korean Macular Telangiectasia Type 2 Study – Report No. 2.

Authors: Kim, Young Ho Chung, Yoo-Ri Oh, Jaeryung et al.

Source: Ophthalmic Epidemiology. Oct2021, Vol. 28 Issue 5, p436-443. 8p.

Characterizing right-angled vessel in macular telangiectasia type 2 with structural optical coherence tomography.

Authors: Chung, Yoo-Ri Kim, Young Ho Oh, Jaeryung et al.

Source: Scientific Reports. 8/25/2021, Vol. 11 Issue 1, p1-5. 5p.

Efficacy of as-needed intravitreal injection compared to 3-monthly loading of anti-vascular endothelial growth factor agents for branch retinal vein occlusion.

Authors: Chung, Yoo-Ri Woo, Tae Kyoung Park, Ha Ryung et al.

Source: Scientific Reports. 7/26/2023, Vol. 13 Issue 1, p1-7. 7p.

Preoperative Parameters Associated with Vitrectomy Outcomes in Myopic Traction Maculopathy Without a Full-Thickness Macular Hole.

Authors: Lee, Su Kyung Yeo, Suji Chung, Yoo-Ri et al.

Source: Life (2075-1729). Feb2026, Vol. 16 Issue 2, p356. 18p.

Role of Inflammation in Classification of Diabetic Macular Edema by Optical Coherence Tomography.

Authors: Chung, Yoo-Ri Kim, Young Ho Ha, Seong Jung et al.

Source: Journal of Diabetes Research. 12/20/2019, p1-9. 9p.

The Association of Pachydrusen Characteristics with Choroidal Thickness and Patient's Age in Polypoidal Choroidal Vasculopathy versus Central Serous Chorioretinopathy.

Authors: Kim, Young Ho Chung, Yoo-Ri Kim, Chungwoon et al.

Source: International Journal of Molecular Sciences. Aug2022, Vol. 23 Issue 15, p8353-8353. 10p.

Changes in the Choroidal Thickness following Intravitreal Bevacizumab Injection in Chronic Central Serous Chorioretinopathy.

Authors: Chung, Yoo-Ri Lee, Su Jeong Song, Ji Hun

Source: Journal of Clinical Medicine. Jun2022, Vol. 11 Issue 12, p3375. 9p.

Changes in Ocular Manifestations of Behçet Disease in Korean Patients over Time: A Single-center Experience in the 1990s and 2000s.

Authors: Chung, Yoo-Ri Lee, Eun-So Kim, Min Ho et al.

Source: Ocular Immunology & Inflammation. Apr2015, Vol. 23 Issue 2, p157-161. 5p.

Effects of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on diabetic retinopathy and its progression: A real-world Korean study.

Authors: Chung, Yoo-Ri Ha, Kyoung Hwa Lee, Kihwang et al.

Source: PLoS ONE. 10/28/2019, Vol. 14 Issue 10, p1-15. 15p.

Real-world treatment intensities and pathways of macular edema following retinal vein occlusion in Korea from Common Data Model in ophthalmology.

Authors: Mun, Yongseok Park, ChulHyoung Lee, Da Yun et al.

Source: Scientific Reports. 6/17/2022, Vol. 12 Issue 1, p1-11. 11p.

Ursodeoxycholic Acid Attenuates Endoplasmic Reticulum Stress-Related Retinal Pericyte Loss in Streptozotocin-Induced Diabetic Mice.

Authors: Chung, Yoo-Ri Choi, Jeong A. Koh, Jae-Young et al.

Source: Journal of Diabetes Research. 1/3/2017, p1-10. 10p.

Optical coherence tomographic features of macular telangiectasia type 2: Korean Macular Telangiectasia Type 2 Study—Report No. 1.

Authors: Kim, Young Ho Chung, Yoo-Ri Oh, Jaeryung et al.

Source: Scientific Reports. 10/6/2020, Vol. 10 Issue 1, pN.PAG-N.PAG. 1p.